ArticleVeterinary sciences2026
Urinary Normetanephrine for the Diagnosis of Canine Pheochromocytoma via Liquid Chromatography-Mass Spectrometry.
Article in Veterinary sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pheochromocytomas (PHEO) are rare adrenal medullary tumours characterised by catecholamine secretion. Accurate diagnosis relies on the sensitive measurement of metanephrine (MN) and normetanephrine (NMN); however, the application of liquid chromatography-mass spectrometry (LC-MS/MS) in veterinary medicine remains limited. This study aimed to develop and analytically validate an LC-MS/MS method for the simultaneous quantification of urinary MN and NMN in dogs, establish reference intervals (RIs) for MN- and NMN-to-creatinine ratios (uMN:CR and uNMN:CR), and preliminarily assess the diagnostic utility of uNMN:CR for PHEO detection. The RIs were 2.2-78.9 nmol/mmol for uMN:CR and 4.4-77.4 nmol/mmol for uNMN:CR. Dogs with PHEO showed significantly higher uNMN:CR values compared with dogs with other adrenal masses, non-adrenal disease, or healthy controls. Using the upper RI limit as a threshold, sensitivity and specificity were 91.7% and 35.7%, respectively. Receiver operating characteristic analysis identified an optimal uNMN:CR cut-off of 203.7 nmol/mmol, yielding 78.6% sensitivity, 83.3% specificity, and an overall diagnostic accuracy of 85% (95% CI: 0.68-1.00). These findings support LC-MS/MS as a reliable approach for urinary metanephrine analysis and uNMN:CR as a valuable biochemical tool for PHEO identification in dogs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.